Price
No data yet.
Social Signal Score
Analyst Ratings
29 analystsRevenue
$235.87M+280.88%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Richard K. Matros
- Sector
- Real Estate
- Industry
- REIT - Healthcare Facilities
- Employees
- 58
- Beta
- 0.64
- Country
- US
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 0.90
Financials
Revenue
$235.87M+280.9%Net Income
$-25.20M-210.7%EBITDA
$29.59M-58.6%Free Cash Flow
$60.66M+54.3%EPS (diluted)
$-0.10-128.6%Shares Outstanding (diluted)
252.27M+284.6%Operating Expenses
$16.82MCash & Debt
$231.58MReturn of Capital
$83.90MRevenue by Segment (annual)
$4.90MDividend per Share
$0.30Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $774.63M | $155.61M | $0.64 |
| 2024 | $703.24M | $126.71M | $0.54 |
| 2023 | $647.51M | $13.76M | $0.06 |
| 2022 | $624.81M | $-77.61M | $-0.34 |
| 2021 | $569.54M | $-113.26M | $-0.52 |
| 2020 | $598.57M | $138.42M | $0.67 |
| 2019 | $668.18M | $69.00M | $0.37 |
| 2018 | $623.41M | $279.08M | $1.57 |
| 2017 | $405.65M | $158.38M | $1.40 |
| 2016 | $260.53M | $70.28M | $0.92 |
| 2015 | $238.86M | $79.41M | $1.11 |
| 2014 | $183.52M | $46.95M | $0.79 |
| 2013 | $134.78M | $33.72M | $0.69 |
| 2012 | $103.17M | $19.51M | $0.53 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from SBRA's reported EPS growth of 1.5% a year over 13 years.
- EPS in 5 years
- $0.69
- Implied price
- $20.84
- Return from $20.27
- 0.6% a year
To earn 15.0% a year on these assumptions you'd need to buy at $10.36 — -48.9% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 20 | 25 | 30 | 35 | 40 |
|---|---|---|---|---|---|
| -8.5% | -16.4% | -12.6% | -9.4% | -6.5% | -4.0% |
| -3.5% | -11.8% | -7.8% | -4.4% | -1.4% | 1.3% |
| 1.5% | -7.3% | -3.0% | 0.6% | 3.7% | 6.5% |
| 6.5% | -2.7% | 1.7% | 5.5% | 8.8% | 11.8% |
| 11.5% | 1.9% | 6.5% | 10.5% | 13.9% | 17.0% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
100-16.67%Social Signal Score
Mentions (2)
- News (RSS)seekingalpha·2h ago·Neutral
Sabra Health Care: This Silver Tsunami Opportunity Is Just Getting Started
View source ↗ - Newsseekingalpha.com·6h ago·Positive
Sabra Health Care: This Silver Tsunami Opportunity Is Just Getting Started Sabra Health Care REIT remains a Buy, supported by improving fundamentals and an attractive valuation amid a strategic pivot to managed senior housing. SBRA reported Q2 2026 normalized AFFO of $0.40 per share, a ~5% YoY increase, with occupancy rising to 85.4% and guidance reaffirmed. Significant investments—$599 million YTD at ~7.5% yield—position SBRA for the Silver Tsunami, despite near-term macro and rate headwinds.
View source ↗
Earnings
Wed, Nov 4(in 7 weeks)
Consensus estimate $0.17 per share
Typical surprise -4.0% (median, so one quarter with a near-zero estimate can't distort it)
- Mon, Aug 3$-0.10 vs $0.17miss
- Wed, Apr 29$0.16 vs $0.17miss
- Thu, Feb 12$0.11 vs $0.17miss
- Wed, Nov 5$0.09 vs $0.18miss
- Mon, Aug 4$0.28 vs $0.18beat
- Mon, May 5$0.17 vs $0.17miss
Estimates and results for SBRA via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by SBRA officers and directors.
- Bought
- —
- Sold
- $4.5m
0 trades
2 trades
- Matros Richard Ksold
- Flores Jessicasold
98 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Daniel Goldmanhouse · NY10 · disclosed May 19, 2023 (39d later)Sell$1,001 - $15,000
- Daniel Goldmanhouse · NY10 · disclosed Apr 17, 2023 (47d later)Buy$1,001 - $15,000
- Chris Jacobshouse · NY27 · disclosed Dec 12, 2022 (34d later)Sell$1,001 - $15,000
- Lois Frankelhouse · FL21 · disclosed Mar 27, 2019 (16d later)Sell$1,001 - $15,000
- Lois Frankelhouse · FL21 · disclosed Mar 27, 2019 (19d later)Sell$1,001 - $15,000
- Greg Gianfortehouse · MT00 · disclosed Jan 23, 2019 (33d later)Buy$50,001 - $100,000
- Gary James Palmerhouse · AL06 · disclosed Sep 29, 2018 (79d later)Buy$1,001 - $15,000
- Gary James Palmerhouse · AL06 · disclosed Sep 29, 2018 (54d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.